Home Biosimilar Antibodies Cytoskeletal Signaling Integrin antibody Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1))
For research use only. Not for use in humans.

Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1))

Synonyms: Anti-alpha5beta1 integrin monoclonal antibody

Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1)) is a monoclonal antibody targeting Integrin a5b1 (ITGA5 & ITGB1). It can be used in treatment of solid tumors, renal cell carcinoma, melanoma, pancreatic cancer, lung cancer, and ovarian cancer. MW :145.52 KD.

Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1))

Quality Control

Batch: Purity: 99% Protein concentration: 9.96mg/ml Endotoxin Level: ＜1EU/mg
99

Specificity

Name Citation Integrin ILK Others
Cilengitide trifluoroacetate 70
A-205804 6
GLPG0187 1
GSK-3008348 HCl 0
Bexotegrast (PLN-74809) 0
Cilengitide 36
OSU-T315 1
TR-14035 0
Cyclo(RGDyK) TFA 14
SB273005 27
RGD (Arg-Gly-Asp) Peptides 26
ILK-IN-3 0
RGD peptide (GRGDNP) 1 caspase-3
ATN-161 22
Cyclo(-RGDfK) TFA 13
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Mechanism of Action

Description
Volociximab (Anti-Integrin a5b1 (ITGA5 & ITGB1)) is a monoclonal antibody targeting Integrin a5b1 (ITGA5 & ITGB1). It can be used in treatment of solid tumors, renal cell carcinoma, melanoma, pancreatic cancer, lung cancer, and ovarian cancer. MW :145.52 KD.
References

Product Details

CAS No. 558480-40-3
Isotype Human IgG4SP
Source CHO
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.